Література - ведення пацієнтів з нестабільною стенокардією / інфарктом міокарда без підйому сегмента st

ЛІТЕРАТУРА

1. Antman EM, Anbe DT, Armstrong PW, et al. ACC / AHA guidelines for the management of patients with ST-elevation myocardial infarction- a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction) J Am Coll Cardiol 2004-44: e1-e211.
2. Smith Jr. SC, Feldman TE, Hirshfeld Jr. JW, et al. ACC / AHA / SCAI 2005 guideline update for percutaneous coronary intervention a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (ACC / AHA / SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) J Am Coll Cardiol 2006-47: e1-e121.
3. Smith Jr. SC, Allen J, Blair SN, et al. AHA / ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute J Am Coll Cardiol 2006-47: 2130-2139.
4. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC / AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology / American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). Доступно на: https://acc.org/qualityandscience. Дійсно на 8 травня 2007 року.
5. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 2007-115: e69-e171.
6. National Heart Attack Alert Program. Emergency Department: rapid identification and treatment of patients with acute myocardial infarction. US Department of Health and Human Services. US Public Health Service. National Institutes of Health. National Heart, Lung and Blood Institute- September 1993- NIH Publication No. 93-3278.
7. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes Circulation 2001-104: 365-372.
8. Hamm CW, Bertrand M, Braunwald E. Acute coronary syndrome without ST elevation: implementation of new guidelines Lancet 2001-358: 1533-1538.
9. Davies MJ. The pathophysiology of acute coronary syndromes Heart 2000-83: 361-366.
10. . Anderson HV, Cannon CP, Stone PH, et al. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial: a randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction J Am Coll Cardiol тисячі дев`ятсот дев`яносто п`ять -26: 1643-1650.
11. Wu AH, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes RJ. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases Clin Chem 1999-45: 1104-1121.
12. Braunwald E. Unstable angina: an etiologic approach to management [editorial] Circulation 1998-98: 2219-2222.
13. DeWood MA, Stifter WF, Simpson CS, et al. Coronary arteriographic findings soon after non-Q-wave myocardial infarction N Engl J Med 1986-315: 417-423.
14. Braunwald E. Unstable angina: a classification Circulation 1989-80: 410-414.
15. Campeau L. Letter: grading of angina pectoris Circulation 1976-54: 522-523.
16. 41318. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 2004-110: 227-239.
17. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 2002-106: 3143-3421.
18. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 2001-285: 2486-2497.
19. Lloyd-Jones DM, Leip EP, Larson MG, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age Circulation 2006- 113: 791-798.
20. Ebrahim S, Davey SG. Multiple risk factor interventions for primary prevention of coronary heart disease Cochrane Database Syst Rev 2000CD001561.
21. Ross SD, Allen IE, Connelly JE, et al. Clinical outcomes in statin treatment trials: a metaanalysis Arch Intern Med 1999-159: 1793-1802.
22. Grundy SM, Pasternak R, Greenland P, Smith Jr. S, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology Circulation 1999-100: 1481-1492.
23. American Heart Association. Risk Assessment. Доступно на: https://americanheart.org/presenter.jhtml?identifier=3003499. Дійсно на 7 серпня 2006.
24. Pearson ТА, Blair SN, Daniels SR, et al. American Heart Association Science Advisory and Coordinating Committee AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases Circulation 2002-106: 388-391.
25. Budoff MJ, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology Circulation 2006-114: 1761-1791 .
26. Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies Arch Intern Med 2000-160: 939-944.
27. Freemantle N, Cleland J, Young P, Mason J, Harrison J. Blockade after myocardial infarction: systematic review and meta regression analysis BMJ 1999-318: 1730-1737.
28. Smith Jr. SC, Blair SN, Bonow RO, et al. AHA / ACC scientific statement: AHA / ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology Circulation 2001-104: 1577-1579 .
29. Mosca L, American Heart Association Cardiology patient page Heart disease prevention in women. Circulation 2004-109: el58-el60.
30. Teo KK, Ounpuu S, Hawken S, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study Lancet 2006-368: 647-658.
31. Office of the Surgeon General. Treating tobacco use and dependence: a clinical practice guideline. Доступно на: https://surgeongeneral.gov/tobacco, 2000. Дійсно на 17 липня 2006.
32. Tonstad S, Tonnesen Р, Hajek Р, Williams КЕ, Billing СВ, Reeves KR. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial JAMA 2006-296: 64-71.
33. Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial JAMA 2006-296: 56-63.
34. Gonzales D, Rennard SI, Nides M, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial JAMA 2006-296: 47-55.
35. 1. U.S. Food and Drug Administration. FDA News. FDA Approves Novel Medication for Smoking Cessation. May 11, 2006. Доступно на:
36. https://fda.gov/bbs/topics/NEWS/2006/NEW01370.html. Дійсно на 15 серпня 2006.
37. Ranney L, Melvin C, Lux L, McClain E, Lohr KN. Systematic review: smoking cessation intervention strategies for adults and adults in special populations Ann Intern Med 2006-145: 845- 856.
38. National Institutes of Health state-of-the-science conference statement: tobacco use: prevention, cessation, and control Ann Intern Med 2006-145: 839-844.
39. Mosca L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women J Am Coll Cardiol 2007-49: 1230-1250.
40. Brown DJ. New guidelines for low-density lipoprotein levels from the National Cholesterol Education Program (NCEP): a 2004 update Prog Cardiovasc Nurs 2004-19: 165.
41. National Institutes of Health Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report Obes Res 1998-6 (Suppl 2): 51S-209S.
42. Department of Health and Human Services. National Institutes of Health. National Heart, Lung, and Blood Institute. Your Guide to Lowering Your Cholesterol with Therapeutic Lifestyle Changes. NIH Publication No. 06-5235. December 2005. Доступно на: https://nhlbi.nih.gov/health/public/heart/chol/chol_tlc.pdf. Дійсно на 27 листопада 2006 року 1. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 2003-289: 2560-2572.
43. Pignone M, Mulrow CD. Evidence based management of hypertension: Using cardiovascular risk profiles to individualize hypertensive treatment BMJ 2001-322: 1164-1166.
44. Lichtenstein AH, Appel LJ, Brands M, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee Circulation 2006-114: 82-96.
45. Thompson PD, Buchner D, Pina IL, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity) Circulation 2003-107: 3109-3116.
46. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism Circulation 2006-113: 898-918.
47. Leon AS, Franklin BA, Costa F, et al. Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity) , in collaboration with the American association of Cardiovascular and Pulmonary Rehabilitation Circulation 2005-111: 369-376.
48. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials Lancet 2003-362: 1527- тисячі п`ятсот тридцять п`ять.
49. SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991-265: 3255-3264.
50. Grundy SM, Howard B, Smith Jr. S, Eckel R, Redberg R, Bonow RO. Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association Circulation 2002-105: 2231-2239.
51. Eckel RH, Kahn R, Robertson RM, Rizza RA. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association Circulation 2006-113: 2943-2946.
52. Hayden M, Pignone M, Phillips C, Mulrow C. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 2002-136: 161-172.
53. U.S. Preventive Services Task Force Aspirin for the primary prevention of cardiovascular events: recommendation and rationale Ann Intern Med 2002-136: 157-160.
54. Peters RJ, Mehta SR, Fox KA, et al. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study Circulation 2003-108: 1682-1687.
55. Hung J. Aspirin for cardiovascular disease prevention Med J Aust 2003-179: 147-152.
56. Abidov A, Rozanski A, Hachamovitch R, et al. Prognostic significance of dyspnea in patients referred for cardiac stress testing N Engl J Med 2005-353: 1889-1898.
57. Goff Jr. DC, Sellers DE, McGovern PG, et al. Knowledge of heart attack symptoms in a population survey in the United States: the REACT TrialRapid Early Action for Coronary Treatment. Arch Intern Med 1998-158: 2329-2338.
58. Goff Jr. DC, Feldman HA, McGovern PG, et al. Rapid Early Action for Coronary Treatment (REACT) Study Group Prehospital delay in patients hospitalized with heart attack symptoms in the United States: the REACT trial Am Heart J 1999-138: 1046-1057.
59. Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3 J Am Coll Cardiol 2000-36: 2056-2063.
60. Welsh RC, Ornato J, Armstrong PW. Prehospital management of acute ST-elevation myocardial infarction: a time for reappraisal in North America Am Heart J 2003-145: 1-8.
61. Goldberg RJ, Steg PG, Sadiq I, et al. Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry) Am J Cardiol 2002-89: 791-796.
62. Finnegan Jr. JR, Meischke H, Zapka JG, et al. Patient delay in seeking care for heart attack symptoms: findings from focus groups conducted in five U.S. regions Prev Med 2000-31: 205-213.
63. Luepker RV, Raczynski JM, Osganian S, et al. Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: the Rapid Early Action for Coronary Treatment (REACT) trial JAMA 2000-284: 60-67.
64. Feldman HA, Proschan MA, Murray DM, et al. Statistical design of REACT (Rapid Early Action for Coronary Treatment), a multisite community trial with continual data collection Control Clin Trials 1998-19: 391-403.
65. Leslie WS, Urie A, Hooper J, Morrison CE. Delay in calling for help during myocardial infarction: reasons for the delay and subsequent pattern of accessing care Heart 2000-84: 137-141.
66. McKinley S, Moser DK, Dracup K. Treatment-seeking behavior for acute myocardial infarction symptoms in North America and Australia Heart Lung 2000-29: 237-247.
67. Rucker D, Brennan T, Burstin H. Delay in seeking emergency care Acad Emerg Med 2001-8: 163-169.
68. посилання видалена.
69. Moser DK, Kimble LP, Alberts MJ, et al. Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on cardiovascular nursing and stroke council Circulation 2006-114: 168-182.
70. Sheifer SE, Gersh BJ, Yanez III ND, Ades PA, Burke GL, Manolio TA. Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly J Am Coll Cardiol 2000-35: 119-126.
71. Kannel WB. Silent myocardial ischemia and infarction: insights from the Framingham Study Cardiol Clin 1986-4: 583-591.
72. Canto JG, Shlipak MG, Rogers WJ, et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain JAMA 2000-283: 3223- 3229.
73. Rathore SS, Weinfurt KP, Gersh BJ, Oetgen WJ, Schulman KA, Solomon AJ. Treatment of patients with myocardial infarction who present with a paced rhythm Ann Intern Med 2001-134: 644-651.
74. Dracup K, Alonzo AA, Atkins JM, et al. Working Group on Educational Strategies To Prevent Prehospital Delay in Patients at High Risk for Acute Myocardial Infarction The physician&rsquo-s role in minimizing prehospital delay in patients at high risk for acute myocardial infarction: recommendations from the National Heart Attack Alert Program Ann Intern Med 1997-126: 645-651.
75. Selker HP, Beshansky JR, Griffith JL, et al. Use of the acute cardiac ischemia time- insensitive predictive instrument (ACI-TIPI) to assist with triage of patients with chest pain or other symptoms suggestive of acute cardiac ischemia: a multicenter, controlled clinical trial Ann Intern Med 1998-129: 845-855 .
76. Faxon D, Lenfant C. Timing is everything: motivating patients to call 9-1-1 at onset of acute myocardial infarction Circulation 2001-104: 1210-1211.
77. National Heart, Lung and Blood Institute, National Institutes of Health. Act in Time to Heart Attack Signs. Доступно на: https://nhlbi.nih.gov/health/public/heart/mi/core_pk.pdf. Дійсно на 27 листопада 2006.
78. U.S. Department of Health and Human Services. Public Health Service. National Institutes of Health. National Heart, Lung and Blood Institute. NIH Publication No. 01-3525. September 2001. https://nhlbi.nih.gov/health/public/heart/mi/core_bk.pdf. Дійсно на 17 липня 2006.
79. U.S. Department of Health and Human Services. Public Health Service. National Institutes of Health. National Heart, Lung and Blood Institute. NIH Publication No. 01-3526. September 2001. Доступно на: https://nhlbi.nih.gov/health/public/heart/mi/core_sp.pdf. Дійсно на 17 липня 2006.
80. U.S. Department of Health and Human Services. Public Health Service. National Institutes of Health. National Heart, Lung and Blood Institute. NIH Publication No. 01-3667. September 2001. Доступно на: https://nhlbi.nih.gov/health/public/heart/mi/wallet.pdf. Дійсно на 17 липня 2006.
81. U.S. Department of Health and Human Services. Public Health Service. National Institutes of Health. National Heart, Lung and Blood Institute. NIH Publication No. 01-3669. September 2001. Доступно на: https://nhlbi.nih.gov/health/public/heart/mi/act_plan.pdf. Дійсно на 17 липня 2006.
82. U.S. Department of Health and Human Services. Public Health Service. National Institutes of Health. National Heart, Lung and Blood Institute. NIH Publication No. 01-3313. September 2001. Доступно на: https://nhlbi.nih.gov/health/prof/heart/mi/provider.pdf. Дійсно на 17 липня 2006.
83. Department of Health and Human Services. Act in Time to Heart Attack Signs: Physician Quick Reference Tool for Palm OS. Public Health Service. National Institutes of Health. National Heart, Lung, and Blood Institute. 2001. Доступно на: https://hin.nhlbi.nih.gov/haac_palm/haac_palm.htm. Дійсно на 17 липня 2006.
84. U.S. Department of Health and Human Services. Public Health Service. National Institutes of Health. National Heart, Lung and Blood Institute. NIH Publication No. 01-3646. September 2001. Доступно на: https://nhlbi.nih.gov/health/public/heart/mi/poster.pdf. Дійсно на 17 липня 2006.
85. Ghali JK, Cooper RS, Kowatly I, Liao Y. Delay between onset of chest pain and arrival to the coronary care unit among minority and disadvantaged patients J Natl Med Assoc 1993-85: 180-184.
86. Hargarten K, Chapman PD, Stueven HA, et al. Prehospital prophylactic lidocaine does not favorably affect outcome in patients with chest pain Ann Emerg Med 1990-19: 1274-1279.
87. Tatum JL, Jesse RL, Kontos MC, et al. Comprehensive strategy for the evaluation and triage of the chest pain patient Ann Emerg Med 1997-29: 116-125.
88. Tatum JL. Cost effective nuclear scanning in a comprehensive and systematic approach to the evaluation of chest pain in the emergency department Md Med J 1997 (Suppl): 25-29.
89. Ornato JP. Chest pain emergency centers: improving acute myocardial infarction care Clin Cardiol 1999-22: IV3-IV9.
90. Newby LK, Storrow AB, Gibler WB, et al. Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study Circulation 2001-103: 1832-1837.
91. Lateef F, Storrow AB, Gibler BW, Liu T. Heart emergency room: effective for both geriatric and younger patients Singapore Med J 2001-42: 259-263.
92. Lateef F, Storrow AB, Malone K, Liu T, Gibler BW. Comparison of a 6-hour and 9-hour protocol for evaluation of moderate-to-low risk chest pain patients in an emergency department diagnostic unit Singapore Med J 2001-42: 52-56.
93. Gibler WB. Chest pain evaluation in the ED: beyond triage Am J Emerg Med 1994- 12: 121122.
94. Gibler WB. Evaluation of chest pain in the emergency department Ann Intern Med 1995-123: 315-318.
95. Gibler WB. Chest pain units: do they make sense now? Ann Emerg Med 1997-29: 168-171.
96. Gibler WB. Evaluating patients with chest pain in the ED: improving speed, efficiency, and cost-effectiveness, or teaching an old dog new tricks Ann Emerg Med 1994-23: 381-382.
97. Hoekstra JW, Gibler WB, Levy RC, et al. Emergency-department diagnosis of acute myocardial infarction and ischemia: a cost analysis of two diagnostic protocols Acad Emerg Med 1994-1: 103-110.
98. Hoekstra JW, Hedges JR, Gibler WB, Rubison RM, Christensen RA, National Cooperative CK-MB Project Group Emergency department CK-MB: a predictor of ischemic complications Acad Emerg Med 1994-1: 17-27.
99. Cannon CP, Hand MH, Bahr R, et al. Critical pathways for management of patients with acute coronary syndromes: an assessment by the National Heart Attack Alert Program Am Heart J 2002-143: 777-789.
100. Zalenski RJ, Selker HP, Cannon CP, et al. National Heart Attack Alert Program position paper: chest pain centers and programs for the evaluation of acute cardiac ischemia Ann Emerg Med 2000-35: 462-471.
101. Lambrew CT, Weaver WD, Rogers WJ, Bowlby LJ, Rubison RM, French WJ. Hospital protocols and policies that may delay early identification and thrombolytic therapy of acute myocardial infarction patients J Thromb Thrombolysis 1996-3: 301-306.
102. Farkouh ME, Smars PA, Reeder GS, et al. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators A clinical trial of a chest-pain observation unit for patients with unstable angina N Engl J Med 1998-339: 1882-1888.
103. Braunwald E, Antman EM, Beasley JW, et al. ACC / AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction -summary article: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) J Am Coll Cardiol 2002-40: 1366-1374.
104. Hedges JR, Feldman HA, Bittner V, et al. REACT Study Group Impact of community intervention to reduce patient delay time on use of reperfusion therapy for acute myocardial infarction: rapid early action for coronary treatment (REACT) trial Acad Emerg Med 2000-7: 862- 872.
105. Canto JG, Zalenski RJ, Ornato JP, et al. Use of emergency medical services in acute myocardial infarction and subsequent quality of care: observations from the National Registry of Myocardial Infarction 2 Circulation 2002-106: 3018-3023.
106. Goldberg R, Goff D, Cooper L, et al. Age and sex differences in presentation of symptoms among patients with acute coronary disease: the REACT TrialRapid Early Action for Coronary Treatment. Coron Artery Dis 2000-11: 399-407.
107. Hutchings CB, Mann NC, Daya M, et al. Patients with chest pain calling 9-1-1 or selftransporting to reach definitive care: which mode is quicker? Am Heart J 2004-147: 35-41.
108. Becker L, Larsen MP, Eisenberg MS. Incidence of cardiac arrest during self-transport for chest pain Ann Emerg Med 1996-18: 612-616.
109. Brown AL, Mann NC, Daya M, et al. Demographic, belief, and situational factors influencing the decision to utilize emergency medical services among chest pain patientsRapid Early Action for Coronary Treatment (REACT) study. Circulation 2000-102: 173-178.
110. Herlitz J, Karlson BW, Liljeqvist JA, Strombom U, Holmberg S. Early identification of acute myocardial infarction and prognosis in relation to mode of transport to hospital Am J Emerg Med 1992-10: 406-412.
111. Ho MT, Eisenberg MS, Litwin PE, Schaeffer SM, Damon SK. Delay between onset of chest pain and seeking medical care: the effect of public education Ann Emerg Med 1989-18: 727-731.
112. Dracup K, Moser DK, Eisenberg M, Meischke H, Alonzo AA, Braslow A. Causes of delay in seeking treatment for heart attack symptoms Soc Sci Med 1995-40: 379-392.
113. Herlitz J, Blohm M, Hartford M, et al. Follow-up of a 1-year media campaign on delay times and ambulance use in suspected acute myocardial infarction Eur Heart J 1992-13: 171-177.
114. Wright RS, Kopecky SL, Timm M, et al. Impact of community-based education on health care evaluation in patients with acute chest pain syndromes: the Wabasha Heart Attack Team (WHAT) project Fam Pract 2001-18: 537-539.
115. Hand M, Brown C, Horan M, Simons-Morton D. Access to timely and optimal care of patients with acute coronary syndromes-community planning considerations: a report by the National Heart Attack Alert Program J Thromb Thrombolysis 1998-6: 19-46 .
116. Simon AB, Feinleib M, Thompson Jr. HK. Components of delay in the pre-hospital phase of acute myocardial infarction Am J Cardiol 1972-30: 476-482.
117. Ryan TJ, Anderson JL, Antman EM, et al. ACC / AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Доступно на: https://acc.org/clinical/guidelines/ami.html. Дійсно на: September 1, 1999..
118. Alonzo AA. The impact of the family and lay others on care-seeking during life-threatening episodes of suspected coronary artery disease Soc Sci Med 1986-22: 1297-1311.
119. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular carePart 7: the era of reperfusion: section 1: acute coronary syndromes (acute myocardial infarction). Circulation 2000-102: I172-I203.
120. McDermott MM, Mandapat AL, Moates A, et al. Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease Arch Intern Med 2003-163: 2157-2162.
121. Newby LK, Califf RM, Guerci A, et al. Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial J Am Coll Cardiol 1996-27: 625-632.
122. Maynard C, Weaver WD, Lambrew C, Bowlby LJ, Rogers WJ, Rubison RM, Participants in the National Registry of Myocardial Infarction Factors influencing the time to administration of thrombolytic therapy with recombinant tissue plasminogen activator (data from the National Registry of Myocardial Infarction) Am J Cardiol 1995-76: 548-552.
123. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy: the Myocardial Infarction Triage and Intervention Trial JAMA 1993-270: 1211-1216.
124. Braunwald E, Mark DB, Jones RH, et al. Unstable Angina: Diagnosis and Management. 31-1994- AHCPR Publication No. 94-0602: 1-154.
125. Pope JH, Ruthazer R, Beshansky JR, Griffith JL, Selker HP. Clinical features of emergency department patients presenting with symptoms suggestive of acute cardiac ischemia: a multicenter study J Thromb Thrombolysis 1998-6: 63-74.
126. Theroux P, Fuster V. Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction Circulation 1998-97: 1195-1206.
127. Savonitto S, Ardissino D, Granger CB, et al. Prognostic value of the admission electrocardiogram in acute coronary syndromes JAMA 1999-281: 707-713.
128. The PURSUIT Trial Investigators Inhibition of platelet glycoprotein IIb / IIIa with eptifibatide in patients with acute coronary syndromesPlatelet Glycoprotein IIb / IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. N Engl J Med 1998-339: 436-443.
129. The TIMI IIIB Investigators Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB TrialThrombolysis in Myocardial Ischemia. Circulation 1994-89: 1545-1556.
130. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators Inhibition of the platelet glycoprotein IIb / IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction (published erratum appears in N Engl J Med 1998-339: 415) N Engl J Med 1998-338: 1488-1497.
131. Chang WC, Boersma E, Granger CB, et al. Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT Am Heart J 2004-148: 62-71.
132. Ronner E, Boersma E, Laarman GJ, et al. Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization: an analysis of the PURSUIT trialPlatelet glycoprotein IIB / IIIA in Unstable angina: Receptor Suppression Using Integrilin Therapy. J Am Coll Cardiol 2002-39: 1924-1929.
133. Theroux P, Alexander Jr. J, Pharand C, et al. Glycoprotein IIb / IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina / non-ST-elevation myocardial infarction: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study Circulation 2000 -102: 2466-2472.
134. Zhao XQ, Theroux P, Snapinn SM, Sax FL. Intracoronary thrombus and platelet glycoprotein IIb / IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction: angiographic results from the PRISM-PLUS trial Circulation 1999-100: 1609-1615.
135. Chaitman BR, Bourassa MG, Davis K, et al. Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS) Circulation 1981-64: 360-367.
136. Pryor DB, Harrell FEJ, Lee KL, Califf RM, Rosati RA. Estimating the likelihood of significant coronary artery disease Am J Med 1983-75: 771-780.
137. Pryor DB, Shaw L, McCants CB, et al. Value of the history and physical in identifying patients at increased risk for coronary artery disease Ann Intern Med 1993-118: 81-90.
138. Morise AP, Haddad WJ, Beckner D. Development and validation of a clinical score to estimate the probability of coronary artery disease in men and women presenting with suspected coronary disease Am J Med 1997-102: 350-356.
139. Ho KT, Miller TD, Hodge DO, Bailey KR, Gibbons RJ. Use of a simple clinical score to predict prognosis of patients with normal or mildly abnormal resting electrocardiographic findings undergoing evaluation for coronary artery disease Mayo Clin Proc 2002-77: 515-521.
140. Kasser IS, Bruce RA. Comparative effects of aging and coronary heart disease on submaximal and maximal exercise Circulation 1969-39: 759-774.
141. Patel H, Rosengren A, Ekman I. Symptoms in acute coronary syndromes: does sex make a difference? Am Heart J 2004-148: 27-33.
142. McSweeney JC, Cody M, O&rsquo-Sullivan P, Elberson K, Moser DK, Garvin BJ. Women&rsquo-s early warning symptoms of acute myocardial infarction Circulation 2003-108: 2619-2623.
143. Lee TH, Cook EF, Weisberg M, Sargent RK, Wilson C, Goldman L. Acute chest pain in the emergency room: identification and examination of low-risk patients Arch Intern Med 1985- 145: 65
144. 69.
145. Pozen MW, D&rsquo-Agostino RB, Selker HP, Sytkowski PA, Hood WBJ. A predictive instrument to improve coronary-care-unit admission practices in acute ischemic heart disease: a prospective multicenter clinical trial N Engl J Med 1984-310: 1273-1278.
146. Selker HP, Griffith JL, D&rsquo-Agostino RB. A tool for judging coronary care unit admission appropriateness, valid for both real-time and retrospective useA time-insensitive predictive instrument (TIPI) for acute cardiac ischemia: a multicenter study. (Published erratum appears in Med Care 1992-30: 188) Med Care 1991-29: 610-627.
147. Henrikson CA, Howell EE, Bush DE, et al. Chest pain relief by nitroglycerin does not predict active coronary artery disease Ann Intern Med 2003-139: 979-986.
148. Swap CJ, Nagurney JT. Value and limitations of chest pain history in the evaluation of patients with suspected acute coronary syndromes JAMA 2005-294: 2623-2629.
149. Brieger DB, Mak KH, White HD, et al. Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial): Global Utilization of Streptokinase and TPA for occluded arteries Am J Cardiol 1998-81: 282-287.
150. Hochman JS, Tamis JE, Thompson TD, et al. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators Sex, clinical presentation, and outcome in patients with acute coronary syndromes N Engl J Med 1999-341: 226-232.
151. Hochman JS, McCabe CH, Stone PH, et al. TIMI Investigators Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIBThrombolysis in Myocardial Infarction. J Am Coll Cardiol 1997-30: 141-148.
152. Scirica BM, Moliterno DJ, Every NR, et al. The GUARANTEE Investigators Differences between men and women in the management of unstable angina pectoris (the GUARANTEE registry) Am J Cardiol 1999-84: 1145-1150.
153. Holmes DRJ, White HD, Pieper F, Ellis SG, Califf RM, Topol EJ. Effect of age on outcome with primary angioplasty versus thrombolysis J Am Coll Cardiol 1999-33: 412-419.
154. White HD, Barbash GI, Califf RM, et al. Age and outcome with contemporary thrombolytic therapy: results from the GUSTO-I trialGlobal Utilization of Streptokinase and TPA for Occluded coronary arteries trial. Circulation 1996-94: 1826-1833.
155. Jayes RLJ, Beshansky JR, D&rsquo-Agostino RB, Selker HP. Do patients&rsquo- coronary risk factor reports predict acute cardiac ischemia in the emergency department? A multicenter study. J Clin Epidemiol 1992-45: 621-626.
156. Michos ED, Vasamreddy CR, Becker DM, et al. Women with a low Framingham risk score and a family history of premature coronary heart disease have a high prevalence of subclinical coronary atherosclerosis Am Heart J 2005-150: 1276-1281.
157. Tadros GM, McConnell TR, Wood GC, Costello JM, Iliadis EA. Clinical predictors of 30- day cardiac events in patients with acute coronary syndrome at a community hospital South Med J 2003-96: 1113-1120.
158. Nasir K, Michos ED, Rumberger JA, et al. Coronary artery calcification and family history of premature coronary heart disease: sibling history is more strongly associated than parental history Circulation 2004-110: 2150-2156.
159. Mak KH, Moliterno DJ, Granger CB, et al. GUSTO-I Investigators Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarctionGlobal Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1997-30: 171-179.
160. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina / non-ST elevation MI: a method for prognostication and therapeutic decision making JAMA 2000-284: 835- 842.
161. Mehta RH, Califf RM, Garg J, et al. The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction Eur Heart J 2006-28: 415-424.
162. Nigam A, Wright RS, Allison TG, et al. Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death Int J Cardiol 2006-110: 153-159.
163. Diercks DB, Roe MT, Mulgund J, et al. The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology / American Heart Association Guidelines Quality Improvement Initiative Am Heart J 2006- 152: 140-148.
164. Rubinshtein R, Halon DA, Jaffe R, Shahla J, Lewis BS. Relation between obesity and severity of coronary artery disease in patients undergoing coronary angiography Am J Cardiol 2006-97: 1277-1280.
165. Jee SH, Sull JW, Park J, et al. Body-mass index and mortality in Korean men and women N Engl J Med 2006-355: 779-787.
166. Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old N Engl J Med 2006-355: 763-778.
167. Romero-Corral A, Montori VM, Somers VK, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies Lancet 2006-368: 666-678.
168. Mittleman MA, Mintzer D, Maclure M, Tofler GH, Sherwood JB, Muller JE. Triggering of myocardial infarction by cocaine Circulation 1999-99: 2737-2741.
169. Eagle KA, Lim MJ, Dabbous OH, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry JAMA 2004-291: 2727-2733.
170. Cohen M, Demers C, Gurfinkel EP, et al. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease N Engl J Med 1997-337: 447-452.
171. Pollack Jr. CV, Sites FD, Shofer FS, Sease KL, Hollander JE. Application of the TIMI risk score for unstable angina and non-ST elevation acute coronary syndrome to an unselected emergency department chest pain population Acad Emerg Med 2006-23: 13-18.
172. Morrow DA, Antman EM, Giugliano RP, et al. A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy Lancet 2001-358: 1571- тисячі п`ятсот сімдесят п`ять.
173. Boersma E, Pieper KS, Steyerberg EW, et al. The PURSUIT Investigators Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevationResults from an international trial of 9461 patients. Circulation 2000-101: 2557-2567.
174. Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital mortality in the global registry of acute coronary events Arch Intern Med 2003-163: 2345-2353.
175. Giugliano RP, Braunwald E. The year in non-ST-segment elevation acute coronary syndromes J Am Coll Cardiol 2005-46: 906-919.
176. Selker HP, Zalenski RJ, Antman EM, et al. An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from a National Heart Attack Alert Program Working Group (published erratum appears in Ann Emerg Med 1997-29: 310) Ann Emerg Med 1997-29: 13-87.
177. Savonitto S, Cohen MG, Politi A, et al. Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes Eur Heart J 2005-26: 2106-2113.
178. Chang WC, Kaul P, Fu Y, et al. Forecasting mortality: dynamic assessment of risk in ST- segment elevation acute myocardial infarction Eur Heart J 2006-27: 419-426.
179. Das M, Aronow WS, McClung JA, Belkin RN. Increased prevalence of coronary artery disease, silent myocardial ischemia, complex ventricular arrhythmias, atrial fibrillation, left ventricular hypertrophy, mitral annular calcium, and aortic valve calcium in patients with chronic renal insufficiency Cardiol Rev 2006-14: 14-17.
180. Coca SG, Krumholz HM, Garg AX, Parikh CR. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease JAMA 2006-296: 1377-1384.
181. Antman EM, McCabe CH, Gurfinkel EP, et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina / non-Q-wave myocardial infarction: results of the Thrombolysis In Myocardial Infarction (TIMI) 11B trial Circulation 1999-100: 1593-1601.
182. Morrow DA, Antman EM, Snapinn SM, McCabe CH, Theroux P, Braunwald E. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromesApplication of the TIMI Risk Score for UA / NSTEMI in PRISM-PLUS. Eur Heart J 2002-23: 223-229.
183. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb / IIIa inhibitor tirofiban N Engl J Med 2001-344: 1879-1887.
184. Zaacks SM, Liebson PR, Calvin JE, Parrillo JE, Klein LW. Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications? J Am Coll Cardiol 1999-33: 107-118.
185. Rouan GW, Lee TH, Cook EF, Brand DA, Weisberg MC, Goldman L. Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms (a report from the Multicenter Chest Pain Study) Am J Cardiol 1989-64 : 1087-1092.
186. Lee TH, Cook EF, Weisberg MC, Rouan GW, Brand DA, Goldman L. Impact of the availability of a prior electrocardiogram on the triage of the patient with acute chest pain J Gen Intern Med 1990-5: 381-388.
187. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury: is MB creatine kinase the choice for the 1990s? Circulation 1993-88: 750-763.
188. Matetzky S, Freimark D, Feinberg MS, et al. Acute myocardial infarction with isolated ST- segment elevation in posterior chest leads V7-9: "hidden" ST-segment elevations revealing acute posterior infarction J Am Coll Cardiol 1999-34: 748-753.
189. Boden WE, Kleiger RE, Gibson RS, et al. Electrocardiographic evolution of posterior acute myocardial infarction: importance of early precordial ST-segment depression Am J Cardiol 1987-59: 782-787.
190. Zalenski RJ, Rydman RJ, Sloan EP, et al. Value of posterior and right ventricular leads in comparison to the standard 12-lead electrocardiogram in evaluation of ST-segment elevation in suspected acute myocardial infarction Am J Cardiol 1997-79: 1579-1585.
191. de Zwaan C, Bar FW, Janssen JH, et al. Angiographic and clinical characteristics of patients with unstable angina showing an ECG pattern indicating critical narrowing of the proximal LAD coronary artery Am Heart J 1989-117: 657-665.
192. Haines DE, Raabe DS, Gundel WD, Wackers FJ. Anatomic and prognostic significance of new T-wave inversion in unstable angina Am J Cardiol 1983-52: 14-18.
193. Renkin J, Wijns W, Ladha Z, Col J. Reversal of segmental hypokinesis by coronary angioplasty in patients with unstable angina, persistent T wave inversion, and left anterior descending coronary artery stenosisAdditional evidence for myocardial stunning in humans. Circulation 1990-82: 913-921.
194. McCarthy BD, Wong JB, Selker HP. Detecting acute cardiac ischemia in the emergency department: a review of the literature J Gen Intern Med 1990-5: 365-373.
195. Slater DK, Hlatky MA, Mark DB, Harrell FEJ, Pryor DB, Califf RM. Outcome in suspected acute myocardial infarction with normal or minimally abnormal admission electrocardiographic findings Am J Cardiol 1987-60: 766-770.
196. Agarwal JB, Khaw K, Aurignac F, LoCurto A. Importance of posterior chest leads in patients with suspected myocardial infarction, but nondiagnostic, routine 12-lead electrocardiogram Am J Cardiol 1999-83: 323-326.
197. Zalenski RJ, Rydman RJ, Sloan EP, et al. ST segment elevation and the prediction of hospital life-threatening complications: the role of right ventricular and posterior leads J Electrocardiol 1998-3 (Suppl): 164-171.
198. Matetzky S, Freimark D, Chouraqui P, et al. Significance of ST segment elevations in posterior chest leads (V7 to V9) in patients with acute inferior myocardial infarction: application for thrombolytic therapy J Am Coll Cardiol 1998-31: 506-511.
199. Bayes de Luna A, Wagner G, Birnbaum Y, et al. A new terminology for left ventricular walls and location of myocardial infarcts that present Q wave based on the standard of cardiac magnetic resonance imaging: a statement for healthcare professionals from a committee appointed by the International Society for Holter and Noninvasive Electrocardiography Circulation 2006-114: 1 755 -1760.
200. Cannon CP, McCabe CH, Stone PH, et al. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary StudyThrombolysis in Myocardial Ischemia. J Am Coll Cardiol 1997-30: 133-140.
201. Ohman EM, Armstrong PW, Christenson RH, et al. GUSTO IIA Investigators Cardiac troponin T levels for risk stratification in acute myocardial ischemia N Engl J Med 1996-335: 1333- тисяча триста сорок одна.
202. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes N Engl J Med 1996-335: 1342-1349.
203. Hyde TA, French JK, Wong CK, Straznicky IT, Whitlock RM, White HD. Four-year survival of patients with acute coronary syndromes without ST- segment elevation and prognostic significance of 0.5-mm ST-segment depression Am J Cardiol 1999-84: 379-385.
204. Lloyd-Jones DM, Camargo CAJ, Lapuerta P, Giugliano RP, O&rsquo-Donnell CJ. Electrocardiographic and clinical predictors of acute myocardial infarction in patients with unstable angina pectoris Am J Cardiol 1998-81: 1182-1186.
205. Brush Jr. JE, Brand DA, Acampora D, Chalmer B, Wackers FJ. Use of the initial electrocardiogram to predict in-hospital complications of acute myocardial infarction N Engl J Med 1985-312: 1137-1141.
206. Fesmire FM, Percy RF, Wears RL, MacMath TL. Risk stratification according to the initial electrocardiogram in patients with suspected acute myocardial infarction Arch Intern Med 1989-849: 1294-1297.
207. Fesmire FM, Percy RF, Wears RL. Diagnostic and prognostic importance of comparing the initial to the previous electrocardiogram in patients admitted for suspected acute myocardial infarction South Med J 1991-84: 841-846.
208. Fesmire FM, Wharton DR, Calhoun FB. Instability of ST segments in the early stages of acute myocardial infarction in patients undergoing continuous 12-lead ECG monitoring Am J Emerg Med 1995-13: 158-163.
209. Fesmire FM, Percy RF, Bardoner JB, Wharton DR, Calhoun FB. Usefulness of automated serial 12-lead ECG monitoring during the initial emergency department evaluation of patients with chest pain Ann Emerg Med 1998-31: 3-11.
210. Kudenchuk PJ, Maynard C, Cobb LA, et al. Utility of the prehospital electrocardiogram in diagnosing acute coronary syndromes: the Myocardial Infarction Triage and Intervention (MITI) project J Am Coll Cardiol 1998-32: 17-27.
211. Langer A, Freeman MR, Armstrong PW. ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome J Am Coll Cardiol 1989-13: 1495-1502.
212. Langer A, Freeman MR, Armstrong PW. Relation of angiographic detected intracoronary thrombus and silent myocardial ischemia in unstable angina pectoris Am J Cardiol 1990-66: 1381- 1 382.
213. Fesmire FM. Delta CK-MB outperforms delta troponin I at 2 hours during the ED rule out of acute myocardial infarction Am J Emerg Med 2000-18: 1-8.
214. Hedges JR, Young GP, Henkel GF, Gibler WB, Green TR, Swanson JR. Serial ECGs are less accurate than serial CK-MB results for emergency department diagnosis of myocardial infarction Ann Emerg Med 1992-21: 1445-1450.
215. Fesmire FM, Hughes AD, Fody EP, et al. The Erlanger chest pain evaluation protocol: a one-year experience with serial 12-lead ECG monitoring, two-hour delta serum marker measurements, and selective nuclear stress testing to identify and exclude acute coronary syndromes Ann Emerg Med 2002-40: 584-594 .
216. Patel DJ, Holdright DR, Knight CJ, et al. Early continuous ST segment monitoring in unstable angina: prognostic value additional to the clinical characteristics and the admission electrocardiogram Heart 1996-75: 222-228.
217. Patel DJ, Knight CJ, Holdright DR, et al. Long-term prognosis in unstable angina: the importance of early risk stratification using continuous ST segment monitoring Eur Heart J 1998-19: 240-249.
218. Hochman JS, Sleeper LA, Godfrey E, et al. The SHOCK Trial Study Group SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK: an international randomized trial of emergency PTCA / CABG-trial design Am Heart J 1999-137: 313-321.
219. Holmes Jr. DR, Berger PB, Hochman JS, et al. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation Circulation 1999-100: 2067-2073.
220. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology / American College of Cardiology Committee for the redefinition of myocardial infarction J Am Coll Cardiol 2000-36: 959-969.
221. Shapiro BP, Jaffe AS. Cardiac biomarkersIn: Murphy JG, Lloyd MA, editors. May Clinic Cardiology: Concise Textbook. 3rd edition. Rochester, MN: Informa Healthcare USA- 2007. pp. 773-780Mayo Clinic Scientific Press and New York, NY.
222. Tsung SH. Several conditions causing elevation of serum CK-MB and CK-BB Am J Clin Pathol 1981-75: 711-715.
223. Christenson RH, Vaidya H, Landt Y, et al. Standardization of creatine kinase-MB (CK-MB) mass assays: the use of recombinant CK-MB as a reference material Clin Chem 1999-45: 1414- 1423.
224. Mair J, Morandell D, Genser N, Lechleitner P, Dienstl F, Puschendorf B. Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction Clin Chem 1995-41: 1266-1272.
225. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease: the present and the future J Am Coll Cardiol 2006-48: 1-11.
226. James SK, Lindahl B, Armstrong P, et al. A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes Int J Cardiol 2004-93: 113-120.
227. Panteghini M, Pagani F, Yeo KT, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations Clin Chem 2004-50: 327-332.
228. Freda BJ, Tang WH, Van Lente F, Peacock WF, Francis GS. Cardiac troponins in renal insufficiency: review and clinical implications J Am Coll Cardiol 2002-40: 2065-2071.
229. Roger VL, Killian JM, Weston SA, et al. Redefinition of myocardial infarction: prospective evaluation in the community Circulation 2006-114: 790-797.
230. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I N Engl J Med 1997-337: 1648-1653.
231. Galvani M, Ottani F, Ferrini D, et al. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina Circulation 1997-95: 2053-2059.
232. Lindahl B, Andren B, Ohlsson J, Venge P, Wallentin L, FRISK Study Group Risk stratification in unstable coronary artery disease: additive value of troponin T determinations and pre-discharge exercise tests Eur Heart J 1997-18: 762-770.
233. Heidenreich PA, Go A, Melsop KA, et al. Prediction of risk for patients with unstable angina Evid Rep Technol Assess 2000: 1-3Summ.
234. Aviles RJ, Askari AT, Lindahl B, et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction N Engl J Med 2002-346: 2047-2052.
235. Wanner C, Krane V, Marz W, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis N Engl J Med 2005-353: 238-248.
236. Dragu R, Behar S, Sandach A, et al. Should primary percutaneous coronary intervention be the preferred method of reperfusion therapy for patients with renal failure and ST-elevation acute myocardial infarction? Am J Cardiol 2006-97: 1142-1145.
237. Han JH, Chandra A, Mulgund J, et al. Chronic kidney disease in patients with non-ST- segment elevation acute coronary syndromes Am J Med 2006-119: 248-254.
238. Masoudi FA, Plomondon ME, Magid DJ, Sales A, Rumsfeld JS. Renal insufficiency and mortality from acute coronary syndromes Am Heart J 2004-147: 623-629.
239. Yan AT, Yan RT, Tan M, et al. Treatment and one-year outcome of patients with renal dysfunction across the broad spectrum of acute coronary syndromes Can J Cardiol 2006-22: 115-120.
240. Wison S, Foo K, Cunningham J, et al. Renal function and risk stratification in acute coronary syndromes Am J Cardiol 2003-91: 1051-1054.
241. Hamm CW, Heeschen C, Goldmann B, et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels: c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators N Engl J Med 1999-340: 1623-1629.
242. Heeschen C, Hamm CW, Goldmann B, Deu A, Langenbrink L, White HD, PRISM Study Investigators Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofibanPlatelet Receptor Inhibition in Ischemic Syndrome Management. Lancet 1999-354: 1757-1762.
243. Lindahl B, Venge P, Wallentin L, Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection J Am Coll Cardiol 1997-29: 43-48.
244. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 2001-345: 494-502.
245. Kastrati A, Mehilli J, Neumann FJ, et al. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial JAMA 2006-295: 1531-1538.
246. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study Lancet 1999-354: 708-715.
247. Kleiman NS, Lakkis N, Cannon CP, et al. Prospective analysis of creatine kinase muscle- brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes J Am Coll Cardiol 2002-40: 1044-1050.
248. Marin MM, Teichman SL. Use of rapid serial sampling of creatine kinase MB for very early detection of myocardial infarction in patients with acute chest pain Am Heart J 1992-123: 354-361.
249. Young GP, Gibler WB, Hedges JR, et al. Serial creatine kinase-MB results are a sensitive indicator of acute myocardial infarction in chest pain patients with nondiagnostic electrocardiograms: the second Emergency Medicine Cardiac Research Group Study Acad Emerg Med 1997-4: 869-877.
250. Apple FS, Christenson RH, Valdes RJ, et al. Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction Clin Chem 1999-45: 199-205.
251. Fesmire FM, Percy RF, Bardoner JB, Wharton DR, Calhoun FB. Serial creatinine kinase (CK) MB testing during the emergency department evaluation of chest pain: utility of a 2-hour deltaCK-MB of + 1.6ng / ml Am Heart J 1998-136: 237-244.
252. Fesmire FM, Peterson ED, Roe MT, Wojcik JF. Early use of glycoprotein IIb / IIIa inhibitors in the ED treatment of non-ST-segment elevation acute coronary syndromes: a local quality improvement initiative Am J Emerg Med 2003-21: 302-308.
253. Lindahl B, Venge P, Wallentin L, The BIOMACS Study Group Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoringBiochemicals Markers of Acute Coronary Syndromes. Coron Artery Dis 1995-6: 321-328.
254. Stork TV, Wu AH, Muller-Bardorff M, et al. North-Wurttemberg Infarction Study (NOWIS) Group Diagnostic and prognostic role of myoglobin in patients with suspected acute coronary syndrome Am J Cardiol 2000-86: 1371-1374.
255. McCord J, Nowak RM, McCullough PA, et al. Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I Circulation 2001-104: 1483-1488.
256. Ng SM, Krishnaswamy P, Morissey R, Clopton P, Fitzgerald R, Maisel AS. Ninety-minute accelerated critical pathway for chest pain evaluation Am J Cardiol 2001-88: 611-617.
257. Sallach SM, Nowak R, Hudson MP, et al. A change in serum myoglobin to detect acute myocardial infarction in patients with normal troponin I levels Am J Cardiol 2004-94: 864-867.
258. de Winter RJ, Lijmer JG, Koster RW, Hoek FJ, Sanders GT. Diagnostic accuracy of myoglobin concentration for the early diagnosis of acute myocardial infarction Ann Em
     
     Поділися в соц мережах:
     
     Увага, тільки СЬОГОДНІ!